These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11453328)

  • 1. PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998.
    Nelson MR; McNeil JJ; Peeters A; Reid CM; Krum H
    Med J Aust; 2001 Jun; 174(11):565-8. PubMed ID: 11453328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
    Siegel D; Lopez J
    JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.
    King MA; Roberts MS
    Pharm World Sci; 2007 Feb; 29(1):39-42. PubMed ID: 17268937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.
    Vaucher J; Marques-Vidal P; Waeber G; Vollenweider P
    Eur J Prev Cardiol; 2018 Jul; 25(10):1111-1113. PubMed ID: 29637794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive use, prescription patterns, and cost of medications in a Teaching Hospital in Lagos, Nigeria.
    Bakare OQ; Akinyinka MR; Goodman O; Kuyinu YA; Wright OK; Adeniran A; Odusanya OO; Osibogun A
    Niger J Clin Pract; 2016; 19(5):668-72. PubMed ID: 27538558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive drug prescribing in Grampian.
    Ross S; Macleod MJ
    Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study.
    Montgomery BD; Mansfield PR; Spurling GK; Ward AM
    BMC Public Health; 2008 May; 8():167. PubMed ID: 18492241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension.
    Ewald BD; Pekarsky B
    Med J Aust; 2002 Feb; 176(4):189; author reply 190. PubMed ID: 11913924
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing trends and drug budget impact of the ARBs in the UK.
    Blak BT; Mullins CD; Shaya FT; Simoni-Wastila L; Cooke CE; Weir MR
    Value Health; 2009; 12(2):302-8. PubMed ID: 18647253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Benefits Scheme restrictions on anti-epileptic drug prescribing promote unsafe and outdated practice.
    Gericke CA; O'Brien TJ
    Med J Aust; 2019 Jul; 211(2):55-57.e1. PubMed ID: 31256431
    [No Abstract]   [Full Text] [Related]  

  • 16. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Benefits Scheme.
    Louis WJ; O'Callaghan CJ; Krum H; Mander AG; Louis ES
    Med J Aust; 1994 Jul; 161(2):174. PubMed ID: 8028551
    [No Abstract]   [Full Text] [Related]  

  • 20. Glaucoma prescribing trends in England 2000 to 2012.
    Connor AJ; Fraser SG
    Eye (Lond); 2014 Jul; 28(7):863-9. PubMed ID: 24858531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.